Essilor has partnered with 14 eye-care professionals to form the Myopia Taskforce. Part of the Myopia Initiative in Action (MIA) program, the team plans to establish recommended protocols for myopia management and detection, which will be shared with the optical community later this year.

Essilor announced its plan at its annual sales meeting in January, when it introduced the members of the taskforce: Thomas Aller, OD, FBCLA; David Anderson, OD; Craig Brawley, OD, FAAO; Mark Bullimore, MCOptom, PhD, FAAO; Alan Glazier, OD, FAAO; John Lahr, OD, FAAO; Maria Liu, OD, PhD; Pamela Lowe, OD, FAAO; Moshe Mendelson, OD, FIAO; Pamela Miller, OD, FAAO, JD, FNAP; Yi Pang, MD, OD, PhD, FAAO; Earl Smith, OD, PhD, FAAO; Long Tran, OD, FAAO; David Troilo, PhD.

“The rate at which the prevalence of myopia is increasing is staggering,” said Millicent Knight, OD, FAAO, FAARM, senior vice president of customer development at Essilor of America. “True to our mission of improving lives by improving sight, we are bringing together some of the industry’s top eyecare professionals with diverse areas of myopia interest and expertise to address this problem together through new research and open collaboration.”
Go to

Alcon has recently launched for U.S.- and Canada-based eyecare professionals (ECPs) and academic institutions. The new website consolidates information about Alcon’s scientific, academic, and related activities into one portal. Visitors may download clinically focused publications, submit grant applications for Investigator-Initiated Trials (IITs), apply for independent medical education support and apply for educational equipment donations, among other activities.
Go to

The American Academy of Ophthalmology (AAO) agrees with important patient safety guidelines recommended in a joint report issued by three federal agencies, the U.S. Departments of Health and Human Services, Treasury, and Labor. The report focuses on reforms that deliver system-wide cost savings, with significant attention paid to the delivery of care at the state level.

One recommendation that the Academy supports is that states forego scope-of-practice expansion when there are legitimate health and safety concerns. Scope-of-practice regulations ensure that only those professionals with the necessary medical education and clinical training are authorized to perform surgical eye procedures.

“Too often there is a rush to extend surgical privileges to those who lack the years of medical education and clinical training necessary for understanding and safely performing critical procedures,” said Keith D. Carter, MD, FACS, president of the AAO, in a statement. “It is critical, certainly in eyecare, that should our states opt to expand scope of practice, that they eschew any dangerous softening of surgical standards and heed the recommendations in this report by preserving regulations that protect patients seeking surgery and complex medical care of eye disease.”
Go to

Bausch + Lomb has received 510(k) clearance from the FDA for Bausch + Lomb ULTRA Multifocal For Astigmatism contact lenses.

Carl Zeiss Meditec has acquired IanTECH, Inc., a privately held company focused on technology solutions for micro-interventional cataract surgery.

Visioneering Technologies Inc. has appointed Brian D. Lane, CPA, as its chief financial officer.

Alcon has acquired Tear Film Innovations, Inc.

Bausch + Lomb has entered into an exclusive agreement with Modulight, Inc., a designer and manufacturer of lasers and optics for personalized medicine, to collaborate and develop a new laser specifically designed for use with Bausch + Lomb’s VISUDYNE (verteporfin for injection) photodynamic therapy (PDT).

Notal Vision, Inc. has announced its first U.S. clinical trial initiated with a home-based, patient-operated, SD-OCT system. The first targeted application of the Notal Home OCT is to monitor exudative (wet) age-related macular degeneration (eAMD) patients between scheduled, standard-of-care examinations by their treating retinal specialist.

Opternative announced its company name changed to Visibly.

ABB OPTICAL GROUP’s specialty lens lab has been approved by Contamac to manufacture gas permeable contact lenses in the Optimum line of GP materials with Tangible Hydra-PEG surfaced coating technology.

Clearside Biomedical submitted new drug application for XIPERE for the treatment of macular edema associated with uveitis.

Atia Vision, a Shifamed portfolio company, closed $10 million in Series C financing.

Ophthotech Corporation announced the election of Adrienne L. Graves, PhD, former chief executive officer of Santen Inc., to its board of directors.

CooperVision’s Specialty Eye Care Division has named two eyecare industry veterans to newly established professional services roles. Elizabeth Lumb, BSc(Hons) MCOptom, FBCLA, has been appointed head of Professional Services, MiSight 1 day, EMEA (Europe, Middle East and Africa) and global brand manager for the lens. Chi Shing Fan, PD Optom, PhD, has been appointed as professional service and commercial lead, MiSight & Specialty Business, Asia Pacific.

Kala Pharmaceuticals has submitted a new drug application to the FDA for KPI-121 0.25%, a topical product candidate for dry eye disease.


Leave A Reply